DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence
Podcast tekijän mukaan DrugPatentWatch
100 Jaksot
-
Introducing DrugChatter: Revolutionizing Information Access
Julkaistiin: 25.6.2024 -
USPTO Study Reveals Trends and Insights into Drug Patent and Exclusivity Trends in the Pharmaceutical Industry
Julkaistiin: 25.6.2024 -
Leveraging 505(b)(2) to Innovate Beyond Existing Drug Patents
Julkaistiin: 24.6.2024 -
The Intricate Journey of Drug Patents: From Filing to Expiry
Julkaistiin: 20.6.2024 -
Uncovering Lucrative Low-Competition Generic Drug Opportunities
Julkaistiin: 19.6.2024 -
Maximizing ROI with Branded Generics: A Comprehensive Guide
Julkaistiin: 18.6.2024 -
A Practical Guide to FtO Analysis for Drug Repurposing Ventures
Julkaistiin: 17.6.2024 -
Divisional Patent Minefields: Navigating Big Pharma’s Patent Extension Strategies
Julkaistiin: 17.6.2024 -
Innovative Approaches to Extend the Life of Drug Patents
Julkaistiin: 17.6.2024 -
How long does a patent last for drugs?
Julkaistiin: 12.6.2024 -
Crucial Insights on Patent Litigation Strategies in Pharma Industry
Julkaistiin: 10.6.2024 -
Underutilized Opportunities: Exploring Patent Term Extensions for Medical Devices
Julkaistiin: 6.6.2024 -
Innovative Strategies in Drug Repurposing
Julkaistiin: 23.4.2024 -
AI-Driven Drug Discovery: Transforming the Landscape of Pharmaceutical Research
Julkaistiin: 16.4.2024 -
Innovative Financing Models for Repurposing Generic Drugs
Julkaistiin: 11.4.2024 -
Biosimilar Competition Does Not Reduce Patient Out-of-Pocket Costs for Biologic Drugs
Julkaistiin: 31.3.2024 -
Unleashing Innovation: The Case for Permissionless R&D in Pharma
Julkaistiin: 22.3.2024 -
LACTOSE-Free Medicines: Which Drugs Contain LACTOSE?
Julkaistiin: 8.3.2024 -
GELATIN-Free Medicines: Which Drugs Contain GELATIN?
Julkaistiin: 6.3.2024 -
Cost-Cut Without Compromise: Navigating Excipient Switching in Pharma
Julkaistiin: 26.2.2024
DrugPatentWatch serves leading companies ranging from biopharmaceutical R&D to healthcare delivery, and has been cited by CNN, NEJM, Nature Journals, and many other leading publications. Use cases for the DrugPatentWatch platform include: - Branded pharmaceutical global business intelligence and forecasting - Generic drug and API manufacturer portfolio management - Wholesalers preventing overstock of off-patent drugs - Healthcare payer formulary management and budget management
